Vasopressin Transdermal Patch 0.4 mg/24hr
Controlled-release transdermal patch delivering 0.4 mg vasopressin over 24 hours for chronic diabetes insipidus management. Note specifies transdermal systems; classified 3004.39.0045 as measured-dose hormone product of heading 2937.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| ๐จ๐ณChina | Free | โ | Free |
| ๐ฒ๐ฝMexico | Free | โ | Free |
| ๐จ๐ฆCanada | Free | โ | Free |
| ๐ฉ๐ชGermany | Free | โ | Free |
| ๐ฏ๐ตJapan | Free | โ | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If other transdermal systems without specified hormones
Vasopressin specificity uses 0045 suffix; general transdermals fall to 9091 statistical breakout.
If imported as wearable medical appliance without drug reservoir
Drug-free patches may classify as Chapter 90 appliances; active medicament controls Chapter 30.
If marketed for cosmetic skin delivery without therapeutic claims
Chapter note excludes beauty preparations; medical hormone use prevents cosmetic shift.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
โข Adhesive matrix composition and permeation testing reports required for device-drug combo clearance
โข Shelf-life extension data critical for transdermal stability during ocean freight
Related Products under HTS 3004.39.00.45
Vasostrict Vasopressin IV Solution 100 Units/5mL
Brand-name Vasostrict intravenous vasopressin solution in 5 mL ampules (20 units/mL concentration) for septic shock and GI hemorrhage treatment. HTS 3004.39.0045 applies to this measured-dose hormone injection containing synthetic vasopressin of heading 2937.
Terlipressin Acetate Injection 1 mg Vial
Synthetic vasopressin analog terlipressin acetate lyophilized powder for injection (1 mg/vial) reconstituted for variceal bleeding control. HTS 3004.39.0045 covers this measured-dose product containing heading 2937 vasopressin-related hormone.
Desmopressin Sublingual Film 120 mcg Strip
Dissolvable oral thin film strips containing 120 mcg desmopressin for rapid absorption in nocturnal enuresis treatment, packaged in individual foil pouches. HTS 3004.39.0045 for this measured-dose vasopressin analog (2937 hormone) in prophylactic form.
Lypressin Intranasal Solution 50 mcg/mL
Lypressin (lysine vasopressin) aqueous nasal solution at 50 mcg/mL concentration in metered pump bottles for diabetes insipidus. Falls under 3004.39.0045 as therapeutic hormone (2937) in measured prophylactic doses.
Vasopressin Injection 20 Units/mL Vial
A sterile injectable solution of vasopressin (synthetic antidiuretic hormone) in a 1 mL single-dose vial, used for treating diabetes insipidus and controlling bleeding during endoscopy. Classified under HTS 3004.39.0045 as a mixed product containing vasopressin (heading 2937 hormone) put up in measured doses for therapeutic use. Excludes goods of headings 3002, 3005, or 3006.
Desmopressin Acetate Nasal Spray 10 mcg/spray
Nasal spray formulation of desmopressin acetate (vasopressin analog) delivering 10 mcg per spray for nocturnal enuresis and diabetes insipidus management. Falls under HTS 3004.39.0045 as it contains a heading 2937 hormone product in measured-dose metered spray for therapeutic prophylactic use.